Proj M

Title : Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38alpha Mitogen-Activated Protein Kinase Inhibitors - Ferjancic Benetik_2025_J.Med.Chem__

Author(s) : Ferjancic Benetik S , Proj M , Knez D , Kosak U , Meden A , Krajsek K , Pislar A , Horvat S , Svajger U , Tesic N , Pulkrabkova L , Soukup O , Skarka A , Andrys R , Brazzolotto X , Igert A , Nachon F , Dias J , Detka J , Gdula-Argasinska J , Wyska E , Szafarz M , Manik A , Plachtij N , Musilek K , Salat K , Obreza A , Gobec S

Ref : Journal of Medicinal Chemistry , : , 2025

Abstract :

PubMedSearch : Ferjancic Benetik_2025_J.Med.Chem__

PubMedID: 40779804

Title : Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic -lactams as inhibitors of penicillin-binding protein(s) - Grabrijan_2024_Acta.Pharm_74_423

Author(s) : Grabrijan K , Benedik NS , Krajnc A , Bozovicar K , Knez D , Proj M , Zdovc I , Sosic I , Contreras-Martel C , Dessen A , Rambaher MH , Gobec S

Ref : Acta Pharm , 74 :423 , 2024

Abstract :

PubMedSearch : Grabrijan_2024_Acta.Pharm_74_423

PubMedID: 39279527

Proj M

References (2)

1. Targeting Neuroinflammation and Cognitive Decline: First-in-Class Dual Butyrylcholinesterase and p38alpha Mitogen-Activated Protein Kinase Inhibitors - Ferjancic Benetik_2025_J.Med.Chem__

2. Synthesis and biochemical evaluation of new 3-amido-4-substituted monocyclic -lactams as inhibitors of penicillin-binding protein(s) - Grabrijan_2024_Acta.Pharm_74_423